Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
FarlaLITE dressing 5cm x 5cm square
20033000106
|
FarlaLITE dressing 5cm x 5cm square | Wound Management & Other Dressings | Dressings | No data available |
|
FarlaSORB dressing 10cm x 10cm square
20031700323
|
FarlaSORB dressing 10cm x 10cm square | Wound Management & Other Dressings | Dressings | No data available |
|
FarlaSORB dressing 10cm x 20cm rectangular
20031700325
|
FarlaSORB dressing 10cm x 20cm rectangular | Wound Management & Other Dressings | Dressings | No data available |
|
FarlaSORB dressing 15cm x 20cm rectangular
20031700326
|
FarlaSORB dressing 15cm x 20cm rectangular | Wound Management & Other Dressings | Dressings | No data available |
|
FarlaSORB dressing 20cm x 20cm square
20031700324
|
FarlaSORB dressing 20cm x 20cm square | Wound Management & Other Dressings | Dressings | No data available |
|
FarlaSORB dressing 20cm x 30cm rectangular
20031700327
|
FarlaSORB dressing 20cm x 30cm rectangular | Wound Management & Other Dressings | Dressings | No data available |
|
FarlaSORB dressing 40cm x 60cm rectangular
20031700328
|
FarlaSORB dressing 40cm x 60cm rectangular | Wound Management & Other Dressings | Dressings | No data available |
|
Farley's Premcare powder
090402000BBMIA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Farley's Soya Formula powder
090401000BBFJA1
|
Proprietary compound foods for special diets | Other food for special diet preparations | Nutrition and Blood | No data available |
|
Farlutal 100 tablets
0803020H0BCAAAC
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farlutal 250 tablets
0803020H0BCABAE
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farlutal 500 suspension for injection 2.5ml vials
0803020H0BCADAB
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farlutal 500 tablets
0803020H0BCACAG
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farmactive Alginato dressing 10cm x 10cm
20030200230
|
Farmactive Alginato dressing 10cm x 10cm | Wound Management & Other Dressings | Dressings | No data available |
|
Farmactive Alginato dressing 10cm x 20cm
20030200231
|
Farmactive Alginato dressing 10cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
|
Farmactive Alginato dressing 5cm x 5cm
20030200229
|
Farmactive Alginato dressing 5cm x 5cm | Wound Management & Other Dressings | Dressings | No data available |
|
Farmactive Alginato Rope dressing 30cm
20030800063
|
Farmactive Alginato Rope dressing 30cm | Wound Management & Other Dressings | Dressings | No data available |
|
Farydak 10mg capsules
0801050BWBBABAB
|
Farydak | Panobinostat | Malignant Disease and Immunosuppression | No data available |
|
Farydak 15mg capsules
0801050BWBBACAC
|
Farydak | Panobinostat | Malignant Disease and Immunosuppression | No data available |
|
Farydak 20mg capsules
0801050BWBBAAAA
|
Farydak | Panobinostat | Malignant Disease and Immunosuppression | No data available |
|
Fasenra 30mg/1ml solution for injection pre-filled pens
0304020AABBABAB
|
Fasenra | Benralizumab | Respiratory System | No data available |
|
Fasenra 30mg/1ml solution for injection pre-filled syringes
0304020AABBAAAA
|
Fasenra | Benralizumab | Respiratory System | No data available |
|
Fasigyn 500mg tablets
0501110G0BBAAAB
|
Fasigyn | Tinidazole | Infections | No data available |
|
Fasturtec 1.5mg inf vials
1001040U0BBAAAA
|
Fasturtec | Rasburicase | Musculoskeletal and Joint Diseases | No data available |
|
Fasturtec 7.5mg inf vials
1001040U0BBABAB
|
Fasturtec | Rasburicase | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.